Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola, Chiara Lanzillotta, Eugenio Barone, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

mTOR as a central regulator of lifespan and aging
David Papadopoli, Karine Boulay, Lawrence Kazak, et al.
F1000Research (2019) Vol. 8, pp. 998-998
Open Access | Times Cited: 352
Effect of rapamycin on aging and age-related diseases—past and future
Ramasamy Selvarani, Sabira Mohammed, Arlan Richardson
GeroScience (2020) Vol. 43, Iss. 3, pp. 1135-1158
Open Access | Times Cited: 200
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Henry Querfurth, Hankyu Lee
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 183
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Annika Höhn, Antonella Tramutola, Roberta Cascella
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 138
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 75
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 48
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 99
Autophagy and apoptosis cascade: which is more prominent in neuronal death?
Rohan Gupta, Rashmi K. Ambasta, Pravir Kumar
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 8001-8047
Open Access | Times Cited: 99
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
Marzia Perluigi, Fabio Di Domenico, Eugenio Barone, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 382-396
Open Access | Times Cited: 92
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
Chiara Lanzillotta, Viviana Greco, Diletta Valentini, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1112-1112
Open Access | Times Cited: 83
Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery
Xiaobo Wang, Jinbao Zhang, Kaijie He, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 76
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Nicole Rummel, D. Allan Butterfield
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 16-18, pp. 1289-1305
Open Access | Times Cited: 70
mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis
Deepthi Rapaka, Veera Raghavulu Bitra, Siva Reddy Challa, et al.
Neurochemistry International (2022) Vol. 155, pp. 105311-105311
Closed Access | Times Cited: 41
Zinc in Cognitive Impairment and Aging
Ruize Sun, Jue Wang, Juan Feng, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 1000-1000
Open Access | Times Cited: 41
Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways
Chencen Lai, Zhuyi Chen, Yuanting Ding, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
Wesley Peng, Georgia Minakaki, Maria Nguyen, et al.
Neurotherapeutics (2019) Vol. 16, Iss. 3, pp. 611-634
Open Access | Times Cited: 70
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, Maria Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 68
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Wileidy Gómez, Rodrigo Morales, Vinicius Maracaja‐Coutinho, et al.
Aging (2020) Vol. 12, Iss. 1, pp. 1011-1033
Open Access | Times Cited: 65
Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease
Ping Yin, Xu Wang, Shuang Wang, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 63
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 957-969
Open Access | Times Cited: 62
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico, Antonella Tramutola, Eugenio Barone, et al.
Redox Biology (2019) Vol. 23, pp. 101162-101162
Open Access | Times Cited: 60
Lymnaea stagnalis as model for translational neuroscience research: From pond to bench
Veronica Rivi, Cristina Benatti, Chiara Colliva, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 602-616
Open Access | Times Cited: 60
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104772-104772
Open Access | Times Cited: 59
Brain Ischemia as a Prelude to Alzheimer's Disease
Ryszard Pluta, Sławomir Januszewski, Stanisław J. Czuczwar
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 55
The role of mTOR in age-related diseases
Žofia Chrienová, Eugenie Nepovimová, Kamil Kuča
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1678-1692
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top